Third-generation EGFR-TKI
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Third-generation EGFR-TKI, covering 2024-06-04 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: TILs Plus Third-Generation EGFR-TKI Therapy for TKI-Resistant NSCLC [EARLY_Phase 1]